163 related articles for article (PubMed ID: 1727666)
21. Expression of a cell surface antigen recognized by the monoclonal antibody AUA1 in bladder carcinoma: an immunohistochemical study.
Zorzos J; Zizi A; Bakiras A; Pectasidis D; Skarlos DV; Zorzos H; Elemenoglou J; Likourinas M
Eur Urol; 1995; 28(3):251-4. PubMed ID: 8536781
[TBL] [Abstract][Full Text] [Related]
22. Changing expression of ABH blood group and cryptic T-antigens of noninvasive and superficially invasive papillary transitional cell carcinoma of the bladder from initial occurrence to malignant progression.
Yamada T; Fukui I; Yokokawa M; Oshima H
Cancer; 1988 Feb; 61(4):721-6. PubMed ID: 3338034
[TBL] [Abstract][Full Text] [Related]
23. Preparation and characterization of monoclonal antibodies directed to the tumor-associated O-linked sialosyl-2----6 alpha-N-acetylgalactosaminyl (sialosyl-Tn) epitope.
Kjeldsen T; Clausen H; Hirohashi S; Ogawa T; Iijima H; Hakomori S
Cancer Res; 1988 Apr; 48(8):2214-20. PubMed ID: 2450649
[TBL] [Abstract][Full Text] [Related]
24. Simple mucin-type carbohydrates in oral stratified squamous and salivary gland epithelia.
Mandel U; Petersen OW; Sørensen H; Vedtofte P; Hakomori S; Clausen H; Dabelsteen E
J Invest Dermatol; 1991 Oct; 97(4):713-21. PubMed ID: 1940443
[TBL] [Abstract][Full Text] [Related]
25. Quantitative morphometry measurements of transitional cell bladder cancer nuclei as indicator of tumor aggression.
De Sanctis PN; Concepcion NB; Tannenbaum M; Olsson C
Urology; 1987 Mar; 29(3):322-4. PubMed ID: 3824735
[TBL] [Abstract][Full Text] [Related]
26. Sialosyl-Le(x) expression defines invasive and metastatic properties of bladder carcinoma.
Numahata K; Satoh M; Handa K; Saito S; Ohyama C; Ito A; Takahashi T; Hoshi S; Orikasa S; Hakomori SI
Cancer; 2002 Feb; 94(3):673-85. PubMed ID: 11857299
[TBL] [Abstract][Full Text] [Related]
27. [Relations of clinicopathological findings to expression of ABH blood group and Thomsen-Friedenrich antigens in initially superficial papillary transitional cell carcinomas of the bladder developing subsequent malignant progression].
Yamada T; Fukui I; Yokogawa M; Oshima H
Nihon Hinyokika Gakkai Zasshi; 1988 Jun; 79(6):1049-53. PubMed ID: 3184579
[No Abstract] [Full Text] [Related]
28. Flow cytometric evaluation of Thomsen-Friedenreich antigen on transitional cell cancer using monoclonal antibody.
Oda H; Oda T; Ohoka H; Yokoyama M; Takeuchi M
Urol Res; 1990; 18(2):107-11. PubMed ID: 2339479
[TBL] [Abstract][Full Text] [Related]
29. [Pathological study of carbohydrate antigens in human lung cancer with monoclonal antibodies].
Kimura S; Saitou D; Kimura K; Yakata M; Hakomori S
Rinsho Byori; 1991 Jul; 39(7):765-72. PubMed ID: 1656116
[TBL] [Abstract][Full Text] [Related]
30. Heterogeneic expression of blood group A and H isoantigens in bladder tumors: association with nuclear volume.
Orntoft TF; Nielsen K
J Histochem Cytochem; 1989 Jul; 37(7):1153-5. PubMed ID: 2732458
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of human carcinoma-associated antigen in urothelial carcinoma of the bladder.
Yao JL; Bourne PA; Yang Q; Lei J; di Sant'Agnese PA; Huang J
Arch Pathol Lab Med; 2004 Jul; 128(7):785-7. PubMed ID: 15214822
[TBL] [Abstract][Full Text] [Related]
32. Simple mucins (T, sialosyl-T, Tn and sialosyl-Tn) are not diagnostic for malignant breast lesions.
Reed W; Bryne M; Clausen H; Dabelsteen E; Nesland JM
Anticancer Res; 1994; 14(2B):609-15. PubMed ID: 7516636
[TBL] [Abstract][Full Text] [Related]
33. Monoclonal antibodies to detect A, B and H blood group isoantigens in superficial transitional cell carcinoma of the bladder: a means of predicting invasive recurrences.
Stephenson TJ; Williams JL; Gelsthorpe K
Br J Urol; 1985 Apr; 57(2):148-53. PubMed ID: 3886066
[TBL] [Abstract][Full Text] [Related]
34. Mucin oligosaccharide biosynthesis in human colonic cancerous tissues and cell lines.
Dahiya R; Itzkowitz SH; Byrd JC; Kim YS
Cancer; 1992 Sep; 70(6):1467-76. PubMed ID: 1515998
[TBL] [Abstract][Full Text] [Related]
35. [Non-invasive urine tests in diagnosis and as prognostic markers for urinary bladder carcinoma. Comparison of the BTAstat and NMP 22 tests with immunocytology using monoclonal antibodies against Lewis X and 486p3/12].
Friedrich MG; Hellstern A; Hautmann SH; Noldus I; Huland H
Urologe A; 2003 Apr; 42(4):523-30. PubMed ID: 12715124
[TBL] [Abstract][Full Text] [Related]
36. [Immunohistochemical determination of antigen 19-9 (CA 19-9) in transitional carcinoma of the bladder].
Casetta G; Cavallini A; Piana P; Squintone L; Vottero M; Tizzani A
Minerva Urol Nefrol; 1992; 44(3):169-72. PubMed ID: 1492266
[TBL] [Abstract][Full Text] [Related]
37. Avidin-biotin technique is more sensitive than lectin assay for detecting the Thomsen-Friedenreich antigen (T-antigen) in transitional cell carcinoma of the bladder.
McAlpine RG; Javadpour N; Vafier JA; Worsham GF; O'Connell KJ
J Surg Oncol; 1984 Dec; 27(4):255-9. PubMed ID: 6389987
[TBL] [Abstract][Full Text] [Related]
38. Expression of SSEA-1 (Lewis(x)) on transitional cell carcinoma of the bladder.
Konety BR; Ballou B; Jaffe R; Singh J; Reiland J; Hakala TR
Urol Int; 1997; 58(2):69-74. PubMed ID: 9096265
[TBL] [Abstract][Full Text] [Related]
39. Ploidy and Tn-antigen expression in the detection of transitional cell neoplasia in non-tumour-bearing patients.
Pinnock CB; Roxby DJ; Ross JM; Pozza CH; Marshall VR
Br J Urol; 1995 Apr; 75(4):461-9. PubMed ID: 7788257
[TBL] [Abstract][Full Text] [Related]
40. Detection of Tn, sialosyl-Tn and T antigens in hereditary nonpolyposis colorectal cancer.
Giuffrè G; Vitarelli E; Tuccari G; Ponz de Leon M; Barresi G
Virchows Arch; 1996 Dec; 429(6):345-52. PubMed ID: 8982378
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
